-
1
-
-
84873918443
-
Activating HER2 mutations in HER2 gene amplification negative breast cancer
-
Bose R, Kavuri SM, Searleman AC et al. Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov 2013; 3: 224-237.
-
(2013)
Cancer Discov
, vol.3
, pp. 224-237
-
-
Bose, R.1
Kavuri, S.M.2
Searleman, A.C.3
-
2
-
-
84878083237
-
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations
-
Ross JS, Wang K, Sheehan CE et al. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clin Cancer Res 2013; 19: 2668-2676.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 2668-2676
-
-
Ross, J.S.1
Wang, K.2
Sheehan, C.E.3
-
3
-
-
84921377658
-
Targeting HER2 for the treatment of breast cancer
-
Rimawi MF, Schiff R, Osborne CK. Targeting HER2 for the treatment of breast cancer. Annu Rev Med 2015; 66: 111-128.
-
(2015)
Annu Rev Med
, vol.66
, pp. 111-128
-
-
Rimawi, M.F.1
Schiff, R.2
Osborne, C.K.3
-
5
-
-
84877028141
-
Comprehensive molecular portraits of human breast tumours
-
Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61-70.
-
(2012)
Nature
, vol.490
, pp. 61-70
-
-
Cancer Genome Atlas, N.1
-
6
-
-
84875740314
-
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
-
Gao J, Aksoy BA, Dogrusoz U et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
-
(2013)
Sci Signal
, vol.6
-
-
Gao, J.1
Aksoy, B.A.2
Dogrusoz, U.3
-
7
-
-
84899981364
-
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
-
Daveau C, Baulies S, Lalloum M et al. Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma. Br J Cancer 2014; 110: 2195-2200.
-
(2014)
Br J Cancer
, vol.110
, pp. 2195-2200
-
-
Daveau, C.1
Baulies, S.2
Lalloum, M.3
-
8
-
-
84895929400
-
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
-
Natrajan R, Wilkerson PM, Marchio C et al. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol 2014; 232: 553-565.
-
(2014)
J Pathol
, vol.232
, pp. 553-565
-
-
Natrajan, R.1
Wilkerson, P.M.2
Marchio, C.3
-
9
-
-
84908867220
-
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
-
Weinreb I, Piscuoglio S, Martelotto LG et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet 2014; 46: 1166-1169.
-
(2014)
Nat Genet
, vol.46
, pp. 1166-1169
-
-
Weinreb, I.1
Piscuoglio, S.2
Martelotto, L.G.3
-
10
-
-
84860782006
-
Absolute quantification of somatic DNA alterations in human cancer
-
Carter SL, Cibulskis K, Helman E et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012; 30: 413-421.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 413-421
-
-
Carter, S.L.1
Cibulskis, K.2
Helman, E.3
-
11
-
-
84874102335
-
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
-
Landau DA, Carter SL, Stojanov P et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714-726.
-
(2013)
Cell
, vol.152
, pp. 714-726
-
-
Landau, D.A.1
Carter, S.L.2
Stojanov, P.3
-
12
-
-
84899752893
-
PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma
-
Sakr RA, Weigelt B, Chandarlapaty S et al. PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma. Clin Cancer Res 2014; 20: 2326-2337.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 2326-2337
-
-
Sakr, R.A.1
Weigelt, B.2
Chandarlapaty, S.3
-
13
-
-
42549111727
-
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
-
Arriola E, Marchio C, Tan DS et al. Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 2008; 88: 491-503.
-
(2008)
Lab Invest
, vol.88
, pp. 491-503
-
-
Arriola, E.1
Marchio, C.2
Tan, D.S.3
-
14
-
-
84911967623
-
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast
-
Piscuoglio S, Ng CK, Martelotto LG et al. Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol Oncol 2014; 8: 1588-1602.
-
(2014)
Mol Oncol
, vol.8
, pp. 1588-1602
-
-
Piscuoglio, S.1
Ng, C.K.2
Martelotto, L.G.3
-
15
-
-
84858391640
-
Functional characterization of the 19q12 amplicon in grade III breast cancers
-
Natrajan R, Mackay A, Wilkerson PM et al. Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 2012; 14: R53.
-
(2012)
Breast Cancer Res
, vol.14
, pp. R53
-
-
Natrajan, R.1
Mackay, A.2
Wilkerson, P.M.3
-
16
-
-
84897445481
-
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
-
Bidard FC, Peeters DJ, Fehm T et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014; 15: 406-414.
-
(2014)
Lancet Oncol
, vol.15
, pp. 406-414
-
-
Bidard, F.C.1
Peeters, D.J.2
Fehm, T.3
-
17
-
-
84864066561
-
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study
-
Blackwell KL, Burstein HJ, Storniolo AM et al. Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study. J Clin Oncol 2012; 30: 2585-2592.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2585-2592
-
-
Blackwell, K.L.1
Burstein, H.J.2
Storniolo, A.M.3
-
18
-
-
84888294653
-
Liver metastases from breast cancer: surgical resection or not? A case-matched control study in highly selected patients
-
Mariani P, Servois V, De Rycke Y et al. Liver metastases from breast cancer: surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol 2013; 39: 1377-1383.
-
(2013)
Eur J Surg Oncol
, vol.39
, pp. 1377-1383
-
-
Mariani, P.1
Servois, V.2
De Rycke, Y.3
|